PSC Research Explained
Summaries of PSC research
Stay informed with PSC Research Explained. We translate the latest clinical trials and scientific breakthroughs into clear, plain English summaries for patients:
New research explores a potential link between Epstein-Barr virus and primary sclerosing cholangitis.
100 samples collected: DNA methylation study advances early cancer detection in PSC.
PSC research on genetic changes in bile ducts is now in its key analytical phase to unlock understanding.
New blood-based markers could help predict primary sclerosing cholangitis progression and cancer risk.
New PSC-IBD research from Dr Chandni Radia suggests bowel cancer risk may be lower than previously thought, helping us build evidence to tailor future colonoscopy guidelines.
New research identifies a marker (COX2) linking lab models to real-world PSC patients, advancing early cancer detection efforts.
Major Progress in Developing Simple Blood Test for Earlier Bile Duct Cancer Detection in PSC
Dr Anthony George shares new insights into immune cells and predicting PSC progression.
PSC Support funding helps uncover new clues in the small intestine for potential new treatments for primary sclerosing cholangitis.
Discover the 2025 breakthroughs in PSC research and how they are shaping 2026.
Our November roundup features encouraging Phase II trial updates, new gut-liver research, and UK policy changes to speed up rare disease treatment access.
Patient survey results shared at major liver conference.
A look at our recent visit to Belfast for the BASL conference and Information Day
Read the latest updates on the SPRING trial, the NHS 10 Year Health Plan, how we are funding research this year and how PSC Support is influencing real change in research and policy.
Research Roundup May 2025 Links Learning from PBC Bile Duct Cancer Conference Research YOU’VE funded International Liver Research Conference (with major PSC announcements) Watch Ask the Expert with Dr Trivedi Learning from PBC This month, I attended a meeting of PBC experts in Amsterdam who want to understand what evidence is required to show that…
Positive results from the Phase 3 NUC-5 clinical trial.